Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis

Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells

(2019) Giuseppe Pettinato et al.   Scientific Reports

Organoid Modeling of the Tumor Immune Microenvironment

(2018) James T. Neal et al.   CELL

An Immunohistochemical Investigation of Renal Phospholipidosis and Toxicity in Rats

(2017) Jing Ying Ma et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease

(2017) Emmanuelle Lecommandeur et al.   JOURNAL OF LIPID RESEARCH

Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation

(2016) Laura Broutier et al.   Nature Protocols

A Mechanistic Study on the Amiodarone-Induced Pulmonary Toxicity

(2016) Bader Al-Shammari et al.   Oxidative Medicine and Cellular Longevity

Glucosylceramide and Lysophosphatidylcholines as Potential Blood Biomarkers for Drug-Induced Hepatic Phospholipidosis

(2014) Kosuke Saito et al.   TOXICOLOGICAL SCIENCES

Are hERG channel blockers also phospholipidosis inducers?

(2013) Hongmao Sun et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity

(2013) Radina Kostadinova et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Drug-induced Liver Steatosis and Phospholipidosis: Cell-Based Assays for Early Screening of Drug Candidates

(2012) M. Teresa Donato et al.   CURRENT DRUG METABOLISM

Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice

(2012) Yoshiji Asaoka et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

High content screening analysis of phospholipidosis: Validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis

(2011) F.M. van de Water et al.   TOXICOLOGY IN VITRO

Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential

(2011) Lloyd LeCureux et al.   TOXICOLOGY IN VITRO

Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration

(2011) Patrick M Chen et al.   Cell and Bioscience

Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities

(2010) Elizabeth A Tengstrand et al.   Expert Opinion on Drug Metabolism & Toxicology

Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity

(2010) Qin Meng   Expert Opinion on Drug Metabolism & Toxicology

A Strategy for Risk Management of Drug-Induced Phospholipidosis

(2009) Linda A. Chatman et al.   TOXICOLOGIC PATHOLOGY

Phospholipidosis Assay in HepG2 Cells and Rat or Rhesus Hepatocytes Using Phospholipid Probe NBD-PE

(2008) Neetesh Bhandari et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Drug-induced Phospholipidosis -Pathological Aspects and Its Prediction

(2008) Takashi Nonoyama et al.   Journal of Toxicologic Pathology

Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures

(2007) C Shen et al.   BRITISH JOURNAL OF PHARMACOLOGY